EUVIMEDEUVIMED entdecken
Open Access

Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis

Maya Aboumrad iD, Gabrielle Zwain, Jeremy Smith, Nabin Neupane, Ethan Powell, Brendan Dempsey, Carolina Reyes, Sacha Satram, Yinong Young-Xu

Military Medicine · 2023

DOI: 10.1093/milmed/usab415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2023. Verfasst von Maya Aboumrad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center, White River Junction, VT 05009, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: VIR Biotechnology Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Early identification of patients with coronavirus disease 2019 (COVID-19) who are at risk for hospitalization may help to mitigate disease burden by allowing healthcare systems to conduct sufficient resource and logistical planning in the event of case surges. We sought to develop and validate a clinical risk score that uses readily accessible information at testing to predict individualized 30-day hospitalization risk following COVID-19 diagnosis.

Methods

We assembled a retrospective cohort of U.S. Veterans Health Administration patients (age ≥ 18 years) diagnosed with COVID-19 between March 1, 2020, and December 31, 2020. We screened patient characteristics using Least Absolute Shrinkage and Selection Operator logistic regression and constructed the risk score using characteristics identified as most predictive for hospitalization. Patients diagnosed before November 1, 2020, comprised the development cohort, while those diagnosed on or after November 1, 2020, comprised the validation cohort. We assessed risk score discrimination by calculating the area under the receiver operating characteristic (AUROC) curve and calibration using the Hosmer–Lemeshow (HL) goodness-of-fit test. This study was approved by the Veteran’s Institutional Review Board of Northern New England at the White River Junction Veterans Affairs Medical Center (Reference no.:1473972-1).

Results

The development and validation cohorts comprised 11,473 and 12,970 patients, of whom 4,465 (38.9%) and 3,669 (28.3%) were hospitalized, respectively. The independent predictors for hospitalization included in the risk score were increasing age, male sex, non-white race, Hispanic ethnicity, homelessness, nursing home/long-term care residence, unemployed or retired status, fever, fatigue, diarrhea, nausea, cough, diabetes, chronic kidney disease, hypertension, and chronic obstructive pulmonary disease. Model discrimination and calibration was good for the development (AUROC = 0.80; HL P-value = .05) and validation (AUROC = 0.80; HL P-value = .31) cohorts.

Conclusions

The prediction tool developed in this study demonstrated that it could identify patients with COVID-19 who are at risk for hospitalization. This could potentially inform clinicians and policymakers of patients who may benefit most from early treatment interventions and help healthcare systems anticipate capacity surges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansMaleAdolescentRetrospective StudiesCOVID-19 TestingRisk FactorsHospitalization

Autor:innen und Institutionen

  • Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center, White River Junction, VT 05009, USA.
  • Division of Health Economics and Outcomes Research, VIR Biotechnology Inc., San Francisco, CA 94158, USA.
  • Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

ORCID-Profile: Maya Aboumrad

Förderung

  • VIR Biotechnology Inc

Zitieren

APA

Aboumrad, M., Zwain, G., Smith, J., Neupane, N., Powell, E., Dempsey, B., Reyes, C., Satram, S., & Young-Xu, Y. (2023). Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis. Military Medicine. https://doi.org/10.1093/milmed/usab415

Vancouver

Aboumrad M, Zwain G, Smith J, Neupane N, Powell E, Dempsey B, et al. Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis. Military Medicine. 2023. doi:10.1093/milmed/usab415

BibTeX
@article{Aboumrad2023,
  author = {Aboumrad, Maya and Zwain, Gabrielle and Smith, Jeremy and Neupane, Nabin and Powell, Ethan and Dempsey, Brendan and Reyes, Carolina and Satram, Sacha and Young-Xu, Yinong},
  title = {Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis},
  journal = {Military Medicine},
  year = {2023},
  doi = {10.1093/milmed/usab415}
}
Kostenlos starten →